Abstract
The present study was carried out in order to develop a transdermal therapeutic system (TTS) for Δ8-THC. The in vitro permeability studies of Δ8-THC in human skin and hairless guinea pig skin with and without a rate-controlling membrane were conducted in flow-through diffusion cells. Δ8-THC pharmacokinetic parameters were determined after topical application of transdermal patches and intravenous administration in guinea pigs. The in vitro results indicated that there was no significant difference in the mean flux or in the permeability coefficient of Δ8-THC in human skin versus hairless guinea pig skin. The flux of Δ8-THC through the human skin/membrane composite was not significantly lower than that through the hairless guinea pig skin/membrane composite; and the skin controlled the Δ8-THC delivery rate. Intravenous doses of Δ8-THC followed a two-compartment model with a significant distribution phase. On application of the TTS patch, the plasma concentration of Δ8-THC reached a mean steady-state level of 4.4 ng/mL within 1.4 h and was maintained for at least 48 h. Significant amounts of metabolites were observed in the plasma after topical application. The in vitro-study predicted plasma concentration following application of the transdermal patch was in agreement with the observed guinea pig plasma concentrations of Δ8-THC. © 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93: 1154–1164, 2004
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
